DONEPEZIL-5 MG. & MEMANTINE-5 MG.

DONEPEZIL-5 MG. & MEMANTINE-5 MG. Specification

Dosage Form
TABLETS

Origin of Medicine
India

Indication
Alzheimers disease

Pacakaging (Quantity Per Box)
10X10 Tablet

Salt Composition
DONEPEZIL-5 MG. & MEMANTINE-5 MG.

Drug Type
General Medicines

Ingredients
DONEPEZIL-5 MG. & MEMANTINE-5 MG.

Physical Form
Tablets

Function
Other

Recommended For
Alzheimers disease

Dosage
TABLETS

Dosage Guidelines
As directed by the physician

Quantity
10000 Boxes

Storage Instructions
Dry Place

DONEPEZIL-5 MG. & MEMANTINE-5 MG. Trade Information

Minimum Order Quantity
10 Strips

Supply Ability
5000 Strips Per Month

Delivery Time
Days

DONEPEZIL-5 MG. & MEMANTINE-5 MG. About

Reduce embarassment reduce struggle with

Ensures predictable response

Provides significant benefits inAlzheimers disease

Improves cognition function and global status of patients

Reduces rates of marked clinical worsening

Provides good safety and tolerability

These results support and extend previous evidence that combinationtreatment with memantine added to stable donepezil in patients withmoderate AD and in those with moderate to severe AD is associatedwith significant benefits in reducing 24week decline in cognitionfunction and global status Combination treatment produces substantiallyreduced rates of marked clinical worsening has good safety and tolerability and generates effectsizes that are both statistically significant and clinically meaningful

Atri A et al Alzheimers Res Ther 2013 Jan 21516

Better than donepezil montherapy

In patients with moderatetosevere AD combination treatment withthe Nmethyldaspartate receptor antagonist memantine and the ChEIdonepezil has produced significant benefits in cognition function

behavior global outcome and care dependency compared withdonepezil treatment alone

Gauthier S Molinuevo JL Alzheimers Dement 2013 May9332631

Reduces risk of nursing home admission

Indicated in

Moderate to severe AD

Other dementia

Tell us about your requirement